About
Contact & Profiles
Research Areas
- Cancer-related gene regulation
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Erythrocyte Function and Pathophysiology
- CRISPR and Genetic Engineering
- Autophagy in Disease and Therapy
- Zebrafish Biomedical Research Applications
- Peptidase Inhibition and Analysis
- Eicosanoids and Hypertension Pharmacology
- Atherosclerosis and Cardiovascular Diseases
- Fatty Acid Research and Health
Boston Children's Hospital
2014-2020
Harvard Stem Cell Institute
2020
Dana-Farber Cancer Institute
2013-2020
Boston Children's Museum
2014
Harvard University
2014
A stem cell reprogramming approach enables disease modeling and drug discovery for a genetic blood disorder uncovers candidate therapeutic.
10.1126/scitranslmed.aah5645
article
EN
Science Translational Medicine
2017-02-08
10.1182/blood-2013-11-540278
article
EN
Blood
2014-05-15
Calmodulin inhibitors rescue erythropoiesis and p53-dependent phenotypes of Diamond-Blackfan anemia.
10.1126/scitranslmed.abb5831
article
EN
Science Translational Medicine
2020-10-21
10.1182/blood.v128.22.332.332
article
EN
Blood
2016-12-02
10.1182/blood.v124.21.359.359
article
EN
Blood
2014-12-06
10.1016/j.exphem.2016.06.063
article
EN
publisher-specific-oa
Experimental Hematology
2016-08-24
10.1016/j.exphem.2014.07.051
article
EN
Experimental Hematology
2014-08-01
10.1182/blood.v126.23.672.672
article
EN
Blood
2015-12-03
10.1182/blood.v122.21.2465.2465
article
EN
Blood
2013-11-15
10.1016/s1567-5688(09)70407-6
article
EN
Atherosclerosis Supplements
2009-06-01
Coming Soon ...